- Home
- NAMS vs FBP Comparison
NAMS vs FBP Comparison
Compare NAMS & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | FBP |
|---|---|---|
| Founded | 2019 | 1948 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | FBP |
|---|---|---|
| Price | $32.46 | $21.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $46.40 | $23.50 |
| AVG Volume (30 Days) | 764.0K | ★ 1.1M |
| Earning Date | 02-25-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | N/A | ★ 13.12 |
| EPS | N/A | ★ 2.05 |
| Revenue | $35,243,000.00 | ★ $902,789,000.00 |
| Revenue This Year | N/A | $16.04 |
| Revenue Next Year | $10.46 | $4.02 |
| P/E Ratio | ★ N/A | $10.37 |
| Revenue Growth | ★ 4.91 | 3.91 |
| 52 Week Low | $14.06 | $16.40 |
| 52 Week High | $42.00 | $22.61 |
Technical Indicators
Market Signals| Indicator | NAMS | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 39.50 | 50.27 |
| Support Level | $30.97 | $20.70 |
| Resistance Level | $32.45 | $21.61 |
| Average True Range (ATR) | 1.64 | 0.44 |
| MACD | -0.24 | -0.04 |
| Stochastic Oscillator | 29.97 | 42.90 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.